Significant Tumor Response to the Poly (ADP-ribose) Polymerase Inhibitor Olaparib in Heavily Pretreated Patient With Ovarian Carcinosarcoma Harboring a Germline RAD51D Mutation

被引：24

作者：

Chandran, Elias A. ^{[1
]}

Kennedy, Ian ^{[1
]}

机构：

[1] Waikato Dist Hlth Board, Pembroke St, Hamilton 3204, Waikato, New Zealand

来源：

JCO PRECISION ONCOLOGY | 2018年 / 2卷

关键词：

HOMOLOGOUS RECOMBINATION; SYNTHETIC LETHALITY; SOMATIC MUTATIONS; PARP-INHIBITION; RUCAPARIB; BRCANESS; CANCER; GENES; BRCA1;

D O I：

10.1200/PO.18.00253

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：1 / 4

页数：4

共 20 条

[1] A synthetic lethal therapeutic approach: Poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair [J].

Ashworth, Alan .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (22) :3785-3790

[2] RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer [J].

Cruz, C. ;

Castroviejo-Bermejo, M. ;

Gutierrez-Enriquez, S. ;

Llop-Guevara, A. ;

Ibrahim, Y. H. ;

Gris-Oliver, A. ;

Bonache, S. ;

Morancho, B. ;

Bruna, A. ;

Rueda, O. M. ;

Lai, Z. ;

Polanska, U. M. ;

Jones, G. N. ;

Kristel, P. ;

de Bustos, L. ;

Guzman, M. ;

Rodriguez, O. ;

Grueso, J. ;

Montalban, G. ;

Caratu, G. ;

Mancuso, F. ;

Fasani, R. ;

Jimenez, J. ;

Howat, W. J. ;

Dougherty, B. ;

Vivancos, A. ;

Nuciforo, P. ;

Serres-Creixams, X. ;

Rubio, I. T. ;

Oaknin, A. ;

Cadogan, E. ;

Barrett, J. C. ;

Caldas, C. ;

Baselga, J. ;

Saura, C. ;

Cortes, J. ;

Arribas, J. ;

Jonkers, J. ;

Diez, O. ;

O'Connor, M. J. ;

Balmana, J. ;

Serra, V .

ANNALS OF ONCOLOGY, 2018, 29 (05) :1203-1210

[3] Synthetic lethality of PARP inhibition in cancers lacking BRCA1 and BRCA2 mutations [J].

Dedes, Konstantin J. ;

Wilkerson, Paul M. ;

Wetterskog, Daniel ;

Weigelt, Britta ;

Ashworth, Alan ;

Reis-Filho, Jorge S. .

CELL CYCLE, 2011, 10 (08) :1192-1199

[4] Synthetic Lethality Triggered by Combining Olaparib with BRCA2-Rad51 Disruptors [J].

Falchi, Federico ;

Giacomini, Elisa ;

Masini, Tiziana ;

Boutard, Nicolas ;

Di Ianni, Lorenza ;

Manerba, Marcella ;

Farabegoli, Fulvia ;

Rossini, Lara ;

Robertson, Janet ;

Minucci, Saverio ;

Pallavicini, Isabella ;

Di Stefano, Giuseppina ;

Roberti, Marinella ;

Pellicciari, Roberto ;

Cavalli, Andrea .

ACS CHEMICAL BIOLOGY, 2017, 12 (10) :2491-2497

[5] DNA recombination: the replication connection [J].

Haber, JE .

TRENDS IN BIOCHEMICAL SCIENCES, 1999, 24 (07) :271-275

[6] The underlying mechanism for the PARP and BRCA synthetic lethality: Clearing up the misunderstandings [J].

Helleday, Thomas .

MOLECULAR ONCOLOGY, 2011, 5 (04) :387-393

[7] Secondary Somatic Mutations Restoring RAD51C and RAD51D Associated with Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma [J].

Kondrashova, Olga ;

Nguyen, Minh ;

Shield-Artin, Kristy ;

Tinker, Anna V. ;

Teng, Nelson N. H. ;

Harrell, Maria I. ;

Kuiper, Michael J. ;

Ho, Gwo-Yaw ;

Barker, Holly ;

Jasin, Maria ;

Prakash, Rohit ;

Kass, Elizabeth M. ;

Sullivan, Meghan R. ;

Brunette, Gregory J. ;

Bernstein, Kara A. ;

Coleman, Robert L. ;

Floquet, Anne ;

Friedlander, Michael ;

Kichenadasse, Ganessan ;

O'Malley, David M. ;

Oza, Amit ;

Sun, James ;

Robillard, Liliane ;

Maloney, Lara ;

Bowtell, David ;

Giordano, Heidi ;

Wakefield, Matthew J. ;

Kaufmann, Scott H. ;

Simmons, Andrew D. ;

Harding, Thomas C. ;

Raponi, Mitch ;

McNeish, Iain A. ;

Swisher, Elizabeth M. ;

Lin, Kevin K. ;

Scott, Clare L. .

CANCER DISCOVERY, 2017, 7 (09) :984-998

[8] Evaluation of the methods to identify patients who may benefit from PARP inhibitor use [J].

Lim, Diana ;

Ngeow, Joanne .

[9] Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition [J].

McCabe, Nuala ;

Turner, Nicholas C. ;

Lord, Christopher J. ;

Kluzek, Katarzyna ;

Bialkowska, Aneta ;

Swift, Sally ;

Giavara, Sabrina ;

O'Connor, Mark J. ;

Tutt, Andrew N. ;

Zdzienicka, Malgorzata Z. ;

Smith, Graeme C. M. ;

Ashworth, Alan .

CANCER RESEARCH, 2006, 66 (16) :8109-8115

[10] Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors [J].

Murai, Junko ;

Huang, Shar-yin N. ;

Das, Benu Brata ;

Renaud, Amelie ;

Zhang, Yiping ;

Doroshow, James H. ;

Ji, Jiuping ;

Takeda, Shunichi ;

Pommier, Yves .

CANCER RESEARCH, 2012, 72 (21) :5588-5599

← 1 2 →